$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Phosphoramidite nucleoside compounds 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-017/00
출원번호 US-0637927 (1984-08-06)
발명자 / 주소
  • Caruthers Marvin H. (Boulder CO) Beaucage Serge L. (Mountain View CA)
출원인 / 주소
  • University Patents, Inc. (Westport CT 02)
인용정보 피인용 횟수 : 262  인용 특허 : 0

초록

A new class of nucleoside phosphoramidites which are relatively stable to permit isolation thereof and storage at room temperature. The phosphoramidites are derivatives of saturated secondary amines.

대표청구항

A compound represented by one of the formulae: [Figure] wherein B is a nucleoside or deoxynucleoside base; A is H, OH or OR4 in which R4 is a blocking group; R′1 is a hydrocarbyl radical containing up to 10 carbon atoms; X is NR′2R′3 wherein R′2 and R′3 taken separately each represents alkyl, aryl,

이 특허를 인용한 특허 (262)

  1. Manoharan Muthiah ; Kawasaki Andrew M. ; Cook Phillip Dan ; Fraser Allister S. ; Prakash Thazha P., 2'-O-acetamido modified monomers and oligomers.
  2. Cook Phillip Dan ; Guinosso Charles John, 2'-O-modified nucleosides and phosphoramidites.
  3. Prakash, Thazha P.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.; Crooke, Stanley T., 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations.
  4. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5'-modified bicyclic nucleic acid analogs.
  5. Swayze, Eric E.; Prakash, Thazha P., 5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom.
  6. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., 5′ modified nucleosides and oligomeric compounds prepared therefrom.
  7. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  8. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  9. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  10. Seth, Punit P.; Swayze, Eric E., 6-disubstituted or unsaturated bicyclic nucleic acid analogs.
  11. Seth, Punit P.; Swayze, Eric E., 6-modified bicyclic nucleic acid analogs.
  12. Seth, Punit P.; Swayze, Eric E., 6-modified bicyclic nucleic acid analogs.
  13. Seth,Punit P.; Swayze,Eric E., 6-modified bicyclic nucleic acid analogs.
  14. Manoharan, Muthia; Ravikumar, Vasulinga T., Activators for oligonucleotide synthesis.
  15. Manoharan, Muthia; Ravikumar, Vasulinga T., Activators for oligonucleotide synthesis.
  16. Sanghvi Yogesh ; Manoharan Muthiah, Activators for oligonucleotide synthesis.
  17. Peck, Konan; Cheng, Ji-Yen, Apparatus and methods for chemical synthesis.
  18. Hoerr, Ingmar; Von Der Mülbe, Florian; Pascolo, Steve, Application of mRNA for use as a therapeutic against tumor diseases.
  19. Hoerr, Ingmar; Von Der Mulbe, Florian; Pascolo, Steve, Application of mRNA for use as a therapeutic against tumour diseases.
  20. Hoerr, Ingmar; Von Der Mülbe, Florian; Pascolo, Steve, Application of mRNA for use as a therapeutic against tumour diseases.
  21. Hoerr, Ingmar; Von Der Mülbe, Florian; Pascolo, Steve, Application of mRNA for use as a therapeutic against tumour diseases.
  22. Hoerr, Ingmar; Von Der Mülbe, Florian; Pascolo, Steve, Application of mRNA for use as a therapeutic against tumour diseases.
  23. Hoerr, Ingmar; Von Der Mülbe, Florian; Pascolo, Steve, Application of mRNA for use as a therapeutic against tumour diseases.
  24. Hoerr, Ingmar; Von Der Mulbe, Florian; Pascolo, Steve, Application of mRNA for use as a therapeutic agent for tumorous diseases.
  25. Myers,Andrew G.; LaPorte,Jacob R.; Xing,Chengguo, Assay for identifying biological targets of polynucleotide-binding compounds.
  26. Shimizu, Mamoru; Wada, Takeshi, Asymmetric auxiliary group.
  27. Smith Lloyd M. ; Hood Leroy E. ; Hunkapiller Michael W. ; Hunkapiller Tim J. ; Connell Charles R., Automated DNA sequencing technique.
  28. Smith Lloyd M. ; Hood Leroy E. ; Hunkapiller Michael W. ; Hunkapiller Tim J. ; Connell Charles R., Automated DNA sequencing technique.
  29. Allerson, Charles; Bhat, Balkrishen; Swayze, Eric E., Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom.
  30. Seth, Punit P.; Swayze, Eric E., Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom.
  31. Seth, Punit P.; Migawa, Michael T.; Swayze, Eric E.; Song, Quanlai; Han, Mingming; Ross, Bruce S., Bicyclic cyclohexitol nucleic acid analogs.
  32. Migawa, Michael T.; Seth, Punit P.; Swayze, Eric E.; Ross, Bruce S.; Song, Quanlai; Han, Mingming, Bicyclic cyclohexose nucleic acid analogs.
  33. Seth, Punit P.; Swayze, Eric E., Bicyclic morpholino compounds and oligomeric compounds prepared therefrom.
  34. Seth, Punit P.; Swayze, Eric E.; Hanessian, Stephen; Schroeder, Benjamin R., Bicyclic nucleosides and oligomeric compounds prepared therefrom.
  35. Seth, Punit P.; Swayze, Eric E., Bis-modified bicyclic nucleic acid analogs.
  36. Seth, Punit P.; Swayze, Eric E., Bis-modified bicyclic nucleic acid analogs.
  37. Phillip Dan Cook ; Haoyun An ; Tingmin Wang ; Muthiah Manoharan, C3'-methylene hydrogen phosphonate monomers and related compounds.
  38. Cook, Phillip Dan; Manoharan, Muthiah; Maier, Martin; An, Haoyun, C3'-methylene hydrogen phosphonate oligomers and related compounds.
  39. Cook, Phillip Dan; Manoharan, Muthiah; Maier, Martin; An, Haoyun, C3′ -methylene hydrogen phosphonate oligomers and related compounds.
  40. Seth, Punit P.; Swayze, Eric E., Carbocyclic bicyclic nucleic acid analogs.
  41. Ecker, David J.; Acevedo, Oscar; Hebert, Normand; Davis, Peter W.; Wyatt, Jacqueline R.; Kiely, John S., Chemical reaction apparatus and methods.
  42. Ecker David J. ; Acevedo Oscar ; Hebert Normand ; Davis Peter W. ; Wyatt Jacqueline R. ; Kiely John S., Chemical reaction apparatus for performing multiple reaction on a surface and collecting the product.
  43. Ecker David J. ; Acevedo Oscar ; Hebert Normand ; Davis Peter W. ; Wyatt Jacqueline R. ; Kiely John S., Chemical synthesis apparatus employing a droplet generator.
  44. Crooke, Stanley T., Chimeric oligomeric compounds and their use in gene modulation.
  45. Butler, David; Iwamoto, Naoki; Meena; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral control.
  46. Butler, David; Iwamoto, Naoki; Meena; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral control.
  47. Meena; Butler, David; Iwamoto, Naoki; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral design.
  48. Gemba, Takefumi, Chiral nucleic acid adjuvant.
  49. Gemba, Takefumi; Nagata, Ryoichi; Torikai, Yusuke, Chiral nucleic acid adjuvant having antitumor effect and antitumor agent.
  50. Gemba, Takefumi; Nagata, Ryoichi; Shiga, Ikumi, Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator.
  51. Krotz, Achim; Capaldi, Daniel C.; Gaus, Hans-Joachim Josef; Turney, Brett, Chloral-free DCA in oligonucleotide synthesis.
  52. Krotz,Achim; Capaldi,Daniel; Gaus,Hans; Turney,Brett, Chloral-free DCA in oligonucleotide synthesis.
  53. Dellinger,Douglas J; Dellinger,Geraldine F; Caruthers,Marvin H, Cleavable linker for polynucleotide synthesis.
  54. Bennett, Clarence Frank; Ecker, David J.; Cook, Phillip Dan, Composition and methods for the pulmonary delivery of nucleic acids.
  55. Chiarello,Ronald H.; Liu,Wing Cheong; Alvarado,Gabriel G., Compositions and methods for labeling oligonucleotides.
  56. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Compositions and methods for modulating HBV expression.
  57. Hoge, Stephen G.; de Fougerolles, Antonin; Ellsworth, Jeff Lynn, Compositions and methods of altering cholesterol levels.
  58. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2'-modified nucleosides for use in gene modulation.
  59. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  60. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression ApoB.
  61. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of DGAT2.
  62. Bhanot, Sanjay; Geary, Richard; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCCR.
  63. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCGR.
  64. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of SGLT2.
  65. Bhat, Balkrishen; Xia, Jie; Seth, Punit P.; Vasquez, Guillermo; Migawa, Michael T.; Allerson, Charles; Prakash, Thazha P.; Swayze, Eric E., Compounds and methods for synthesis of bicyclic nucleic acid analogs.
  66. Capaldi,Daniel C.; Gaus,Hans Joachim Josef; Rentel,Claus Andre Frank; Olsen,Philip Dmitri; Kurata,Christine C.; Song,Quanlai, Compounds and methods for the characterization of oligonucleotides.
  67. Richard H. Griffey ; Douglas L. Cole ; Vasulinga Ravikumar, Compounds for the Synthesis of Nucleotide or oligonucleotide phosphoramidites.
  68. Richard H. Griffey ; Douglas L. Cole ; Vasulinga Ravikumar, Compounds for the synthesis of nucleotide or oligonucleotide phosphoramidites.
  69. Manoharan Muthiah ; Maier Martin A., Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds.
  70. Muthiah Manoharan ; Martin A. Maier, Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds.
  71. Bennett, C. Frank; McKay, Robert; Monia, Brett P.; Baker, Brenda F.; Sioufi, Namir, Conjugates for use in hepatocyte free uptake assays.
  72. Verthelyi, Daniela; Beaucage, Serge L.; Grajkowski, Andrzej, CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods.
  73. Wood, Bradford J.; Dreher, Matthew; Negussie, Ayele H., Cyclized NGR peptide compounds, compositions, and methods of their use.
  74. Seth, Punit P.; Swayze, Eric E., Cyclohexenyl nucleic acids analogs.
  75. Seth, Punit P.; Swayze, Eric E., Cyclohexenyl nucleic acids analogs.
  76. de Fougerolles, Antonin; Wood, Kristy M.; Elbashir, Sayda M.; Schrum, Jason P., DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides.
  77. Brandis, John; Bloom, Curtis; Richards, John H., DNA polymerases having improved labeled nucleotide incorporation properties.
  78. De Fougerolles, Antonin; Elbashir, Sayda M., Delivery and formulation of engineered nucleic acids.
  79. de Fougerolles, Antonin; Elbashir, Sayda M., Delivery and formulation of engineered nucleic acids.
  80. Smith Lloyd M. (South Pasadena CA) Fung Steven (Palo Alto CA), Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for t.
  81. Cole, Douglas L.; Ravikumar, Vasulinga, Diribonucleoside Phosphoramidites.
  82. Baker, Brenda F.; Kraynack, Bryan A., Double stranded constructs comprising one or more short strands hybridized to a longer strand.
  83. Cook, Zhihong C.; Medrano, Leonard, Early light-induced protein promoters.
  84. Bancel, Stephane; Schrum, Jason P.; Aristarkhov, Alexander, Engineered nucleic acids and methods of use thereof.
  85. Bancel, Stephane; Schrum, Jason P.; Aristarkhov, Alexander, Engineered nucleic acids and methods of use thereof.
  86. Schrum, Jason P.; Bancel, Stephane; Afeyan, Noubar B., Engineered nucleic acids and methods of use thereof.
  87. Schrum, Jason P.; Bancel, Stephane; Afeyan, Noubar B.; Ejebe, Kenechi, Engineered nucleic acids and methods of use thereof.
  88. Schrum, Jason P.; Bancel, Stephane; Afeyan, Noubar B.; Ejebe, Kenechi, Engineered nucleic acids and methods of use thereof.
  89. Schrum, Jason P.; Bancel, Stéphane; Afeyan, Noubar B., Engineered nucleic acids and methods of use thereof.
  90. Schrum, Jason P.; Sieczkiewicz, Gregory J.; Ejebe, Kenechi; Elbashir, Sayda M., Engineered nucleic acids and methods of use thereof.
  91. Schrum, Jason P.; Afeyan, Noubar B.; Sieczkiewicz, Gregory J.; Bancel, Stephane; de Fougerolles, Antonin; Elbashir, Sayda M., Engineered nucleic acids encoding a modified erythropoietin and their expression.
  92. Shepard, H. Michael; Chan, Ming Fai; Groziak, Michael P., Enzyme catalyzed therapeutic activation.
  93. Shepard, H. Michael; Groziak, Michael P., Enzyme catalyzed therapeutic agents.
  94. Shepard, H. Michael; Chan, Ming Fai; Groziak, Michael P., Enzyme catalyzed therapeutic compounds.
  95. de Fougerolles, Antonin; Wood, Kristy M.; Valencia, Pedro, Formulation and delivery of PLGA microspheres.
  96. de Fougerolles, Antonin; Wood, Kristy M.; Valencia, Pedro, Formulation and delivery of PLGA microspheres.
  97. Sanghvi, Yogesh S.; Manoharan, Muthiah, Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages.
  98. Manoharan, Muthiah; Cook, Phillip Dan; Prakash, Thazha P.; Mohan, Venkatraman, Guanidinium functionalized intermediates.
  99. Manoharan, Muthiah; Cook, Phillip Dan; Prakash, Thazha P.; Mohan, Venkatraman, Guanidinium functionalized nucleotides and precursors thereof.
  100. Manoharan, Muthiah; Cook, Phillip Dan; Prakash, Thazha P.; Mohan, Venkatraman, Guanidinium functionalized oligonucleotides and method/synthesis.
  101. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, In vivo production of proteins.
  102. Cheruvallath, Zacharia S.; Ravikumar, Vasulinga T.; Cole, Douglas L., Intermediates for the synthesis of oligonucleotide analogues.
  103. Manoharan, Muthiah; Guzaev, Andrei P., Labeled oligonucleotides, methods for making same, and compounds useful therefor.
  104. Wan, W. Brad; Migawa, Michael T.; Oestergaard, Michael; Swayze, Eric E.; Seth, Punit P., Linkage modified oligomeric compounds.
  105. Koester Hubert (Concord MA) Coull James M. (Acton MA), Membranes with bound oligonucleotides and peptides.
  106. Kumagai Monto H. ; della-Cioppa Guy R., Method for conferring herbicide, pest, or disease resistance in plant hosts.
  107. Dellinger,Douglas J; Sierzchala,Agnieszka B.; Caruthers,Marvin H; Dellinger,Geraldine F, Method for polynucleotide synthesis.
  108. Adamo, Ilaria; Dueymes, Cecile; Schonberger, Andreas; Imbach, Jean-Louis; Meyer, Albert; Morvan, Francois; Debart, Francoise; Vasseur, Jean-Jacques; Lange, Meinolf; Link, Fritz, Method for preparing oligonucleotides.
  109. de Fougerolles, Antonin; Wood, Kristy M.; Elbashir, Sayda M.; Schrum, Jason P., Method for producing a protein of interest in a primate.
  110. Chreng, Dana, Method for solution phase detritylation of oligomeric compounds.
  111. Pieken Wolfgang ; McGee Danny ; Settle Alecia ; Zhai Yansheng ; Huang Jianping, Method for solution phase synthesis of oligonucleotides.
  112. Migawa, Michael T.; Yu, Jinghua; Wan, W. Brad; Patel, Satyen P.; Vasquez, Guillermo; Kinberger, Garth A.; Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Method for synthesis of reactive conjugate clusters.
  113. Griffey Richard H. ; Cole Douglas L. ; Ravikumar Vasulinga, Method for the synthesis of nucleotide or oligonucleotide phosphoramidites.
  114. Griffey Richard H. ; Cole Douglas L. ; Ravikumar Vasulinga T., Method for the synthesis of nucleotide or oligonucleotide phosphoramidites.
  115. Wada, Takeshi; Shimizu, Mamoru, Method for the synthesis of phosphorus atom modified nucleic acids.
  116. Wada, Takeshi; Shimizu, Mamoru, Method for the synthesis of phosphorus atom modified nucleic acids.
  117. Monto H. Kumagai ; Guy R. della-Cioppa ; Robert L. Erwin ; David R. McGee, Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation.
  118. Dellinger, Douglas J; Dellinger, Geraldine F; Hargreaves, John S, Method of polynucleotide synthesis using modified support.
  119. Cedillo, Isaiah E.; Janczak, Darren; Weaver, Phillip Michael, Method of preparing oligomeric compounds using modified capping protocols.
  120. Cedillo, Isaiah E.; Migawa, Michael T.; Wan, W. Brad, Method of preparing oligomeric compounds using modified coupling protocols.
  121. Alessandra Eleuteri ; Daniel C. Capaldi ; Vasulinga T. Ravikumar, Method of preparing phosphoramidites.
  122. Cole Douglas L. ; Ravikumar Vasulinga, Method of synthesizing phosphorothioate oligonucleotides.
  123. Douglas L. Cole ; Vasulinga Ravikumar, Method of synthesizing phosphorothioate oligonucleotides.
  124. Achim H. Krotz ; Bethany M. McElroy ; Anthony N. Scozzari, Methods for removing dimethoxytrityl groups from oligonucleotides.
  125. Krotz, Achim H.; McElroy, Bethany M.; Scozzari, Anthony N., Methods for removing dimethoxytrityl groups from oligonucleotides.
  126. Krotz,Achim H.; Ravikumar,Vasulinga T., Methods for synthesis of oligonucleotides.
  127. Muthiah Manoharan, Methods for the preparation of conjugated oligomers.
  128. Verdine, Gregory L.; Meena; Iwamoto, Naoki; Butler, David Charles Donnell, Methods for the synthesis of functionalized nucleic acids.
  129. Shepard,H. Michael, Methods for treating therapy-resistant tumors.
  130. Prakash, Thazha P.; Seth, Punit P.; Manoharan, Muthiah; Swayze, Eric E.; Rajeev, Kallanthottathil G.; Zlatev, Ivan, Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom.
  131. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom.
  132. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom.
  133. Schrum, Jason P.; Siddiqi, Suhaib; Ejebe, Kenechi, Modified nucleosides, nucleotides, and nucleic acids, and uses thereof.
  134. Schrum, Jason P.; Siddiqi, Suhaib; Ejebe, Kenechi, Modified nucleosides, nucleotides, and nucleic acids, and uses thereof.
  135. Schrum, Jason P.; Siddiqi, Suhaib; Ejebe, Kenechi, Modified nucleosides, nucleotides, and nucleic acids, and uses thereof.
  136. de Fougerolles, Antonin; Roy, Atanu; Schrum, Jason P.; Siddiqi, Suhaib; Hatala, Paul; Bancel, Stephane, Modified nucleosides, nucleotides, and nucleic acids, and uses thereof.
  137. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1.
  138. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding apoptosis inducing factor 1.
  139. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding aquaporin-5.
  140. Chakraborty, Tirtha; de Fougerolles, Antonin; Weiss, Ron, Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator.
  141. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding basic helix-loop-helix family member E41.
  142. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding citeD4.
  143. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1.
  144. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding granulysin.
  145. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Whoriskey, Susan; Weiss, Ron, Modified polynucleotides encoding hepatitis A virus cellular receptor 2.
  146. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides encoding septin-4.
  147. de Fougerolles, Antonin; Wood, Kristy M.; Elbashir, Sayda M.; Schrum, Jason P., Modified polynucleotides for the production of G-CSF.
  148. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, Modified polynucleotides for the production of biologics and proteins associated with human disease.
  149. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, Modified polynucleotides for the production of biologics and proteins associated with human disease.
  150. Bancel, Stephane; Huang, Eric Yi-Chun, Modified polynucleotides for the production of cosmetic proteins and peptides.
  151. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins.
  152. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins.
  153. Chakraborty, Tirtha; de Fougerolles, Antonin; Weiss, Ron, Modified polynucleotides for the production of nuclear proteins.
  154. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, Modified polynucleotides for the production of oncology-related proteins and peptides.
  155. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; Ellsworth, Jeff Lynn; Ejebe, Kenechi; Guild, Justin; John, Matthias; Hatala, Paul; Roy, Atanu; Schrum, Jason P.; Whoriskey, Susan; Wood, Kristy M., Modified polynucleotides for the production of proteins.
  156. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, Modified polynucleotides for the production of proteins.
  157. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders.
  158. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders.
  159. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, Modified polynucleotides for the production of proteins associated with human disease.
  160. Bancel, Stephane; Chakraborty, Tirtha; de Fougerolles, Antonin; Elbashir, Sayda M.; John, Matthias; Roy, Atanu; Whoriskey, Susan; Wood, Kristy M.; Hatala, Paul; Schrum, Jason P.; Ejebe, Kenechi; Ellsworth, Jeff Lynn; Guild, Justin, Modified polynucleotides for the production of secreted proteins.
  161. Chakraborty, Tirtha; de Fougerolles, Antonin, Modified polynucleotides for the production of secreted proteins.
  162. Chakraborty, Tirtha; de Fougerolles, Antonin; Weiss, Ron, Modified polynucleotides for treating galactosylceramidase protein deficiency.
  163. Chakraborty, Tirtha; de Fougerolles, Antonin; Weiss, Ron, Modified polynucleotides for treating protein deficiency.
  164. Rusconi, Christopher P., Modulators of coagulation factors with enhanced stability.
  165. Van Gelder,Russell N.; Von Zastrow,Mark E.; Barchas,Jack D.; Eberwine,James H., Multi-gene expression profile.
  166. Van Gelder Russell N. ; Von Zastrow Mark E. ; Barchas Jack D. ; Eberwine James D., Multi-genes expression profile.
  167. Beaucage, Serge L.; Wilk, Andrzej; Grajkowski, Andrzej, N-acylphosphoramidites and their use in oligonucleotide synthesis.
  168. Prakash, Thazha P.; Bhat, Balkrishin; Swayze, Eric E., N-substituted-aminomethylene bridged bicyclic nucleic acid analogs.
  169. Mock Graham A. (Northborough MA) Lovern Douglas H. (Milford MA), N4-substituted 2′-deoxycytidine compounds, oligonucleotides including N4-labeled 2′-deoxyc.
  170. Hu, A-Li W.; Hartley, James L.; Jordan, Heather J., Nucleic acid ladders.
  171. Jordan, Heather J., Nucleic acid ladders.
  172. Verdine, Gregory L.; ., Meena; Iwamoto, Naoki, Nucleic acid prodrugs and methods of use thereof.
  173. Engelhardt, Dean; Rabbani, Elazar; Kline, Stanley; Stavrianopoulos, Jannis G.; Kirtikar, Dollie, Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs.
  174. Caruthers Marvin H. (Boulder CO) Brill Wolfgang K. D. (Schopfheim DEX) Yau Eric (Mercer Island WA) Ma Michael (New York NY) Nielsen John (Horsholm DKX), Nucleoside thiophosphoramidites.
  175. Ravikumar, Vasulinga T.; Capaldi, Daniel C.; Cole, Douglas L., Oligomer phosphoramidite compositions and processes for synthesizing the same.
  176. Swayze, Eric E.; Bhat, Balkrishen; Lima, Walter F.; Prakash, Thazha P.; Kinberger, Garth A., Oligomeric compounds and methods.
  177. Swayze, Eric E.; Bhat, Balkrishen; Lima, Walter F.; Prakash, Thazha P.; Kinberger, Garth A., Oligomeric compounds and methods.
  178. Oestergaard, Michael; Swayze, Eric E.; Seth, Punit P., Oligomeric compounds comprising alpha-beta-constrained nucleic acid.
  179. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucelosides and methods for their use.
  180. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucelosides and methods for their use.
  181. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucleosides and methods for their use.
  182. Seth, Punit P.; Swayze, Eric E., Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside.
  183. Cook,Phillip Dan; Manoharan,Muthiah, Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages.
  184. Moore,Max N.; Andrade,Mark; Carty,Recaldo; Scozzari,Anthony; Krotz,Achim, Oligonucleotide synthesis with alternative solvents.
  185. Phillip Dan Cook ; Muthiah Manoharan, Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages.
  186. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  187. Von Der Mülbe, Florian; Hoerr, Ingmar; Pascolo, Steve, Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions.
  188. Guzaev Andrei P. ; Manoharan Muthiah, Phosphate and thiophosphate protecting groups.
  189. Guzaev, Andrei P.; Manoharan, Muthiah, Phosphate and thiophosphate protecting groups.
  190. Shepard,H. Michael; Vaino,Andrew Rein; Lehsten,Danielle M., Phosphoramidate compounds and methods of use.
  191. Guzaev, Andrei Pavel; Vvedenskiy, Vladimir Y., Phosphoramidite building blocks for sugar-conjugated oligonucleotides.
  192. Imbach Jean-Louis,FRX ; Gosselin Gilles,FRX ; Rayner Bernard,FRX, Phosphotriester oligonucleotides, amidites and method of preparation.
  193. Imbach Jean-Louis,FRX ; Gosselin Gilles,FRX ; Rayner Bernard,FRX ; Manoharan Muthiah, Phosphotriester oligonucleotides, amidities and method of preparation.
  194. Caruthers Marvin H. (Boulder CO) Brill Wolfgang K.-D. (Schopfheim DEX) Yau Eric (Mercer Island WA) Ma Michael (New York NY) Nielsen John (Horsholm DKX), Polynucleotide phosphorodithioate compounds.
  195. Bhat, Balkrishen; Swayze, Eric E.; Prakash, Thazha P.; Allerson, Charles; Dande, Prasad; Griffey, Richard H., Positionally modified siRNA constructs.
  196. Dellinger,Douglas J.; Sierzchala,Agnieszka B.; Caruthers,Marvin H., Precursors for two-step polynucleotide synthesis.
  197. Just George,CAX ; Xin Zhili ; Marsault Eric,CAX ; Jin Yi,CAX ; Wang Jianchao,CAX ; Manoharan Muthiah, Preparation of phosphorothioate and boranophosphate oligomers.
  198. George Just CA; Zhili Xin ; Eric Marsault CA; Yi Jin CA; Jianchao Wang CA, Preparation of phosphorothioate oligomers.
  199. Just George,CAX ; Xin Zhili,CAX ; Marsault Eric,CAX ; Jin Yi,CAX, Preparation of phosphorothioate oligomers.
  200. Just George,CAX ; Xin Zhili,CAX ; Marsault Eric,CAX ; Jin Yi,CAX, Preparation of phosphorothioate oligomers.
  201. Just, George; Xin, Zhili; Marsault, Eric; Jin, Yi, Preparation of phosphorothioate oligomers.
  202. Just, George; Xin, Zhili; Marsault, Eric; Jin, Yi; Wang, Jianchao, Preparation of phosphorothioate oligomers.
  203. Scozzari Anthony, Process for oligonucleotide synthesis.
  204. Ishido Yoshiharu (Tokyo JPX) Kamaike Kazuo (Tokyo JPX), Process for synthesis of oligonucleotides and compound for forming polymeric protecting group.
  205. Capaldi Daniel C. ; Ravikumar Vasulinga T., Process for the synthesis of oligomeric compounds.
  206. Capaldi Daniel C. ; Ravikumar Vasulinga T., Process for the synthesis of oligomeric compounds.
  207. Cheruvallath Zacharia S. ; Ravikumar Vasulinga T. ; Cole Douglas L., Process for the synthesis of oligomeric compounds.
  208. Cheruvallath, Zacharia S.; Ravikumar, Vasulinga T.; Cole, Douglas L., Process for the synthesis of oligomeric compounds.
  209. Ravikumar Vasulinga T., Process for the synthesis of oligomeric compounds.
  210. Ravikumar, Vasulinga T.; Manoharan, Muthiah; Capaldi, Daniel C.; Krotz, Achim; Cole, Douglas L.; Guzaev, Andrei, Process for the synthesis of oligomeric compounds.
  211. Ravikumar,Vasulinga T.; Manoharan,Muthiah; Capaldi,Daniel C.; Krotz,Achim; Cole,Douglas L.; Guzaev,Andrei, Process for the synthesis of oligomeric compounds.
  212. Ravikumar,Vasulinga T.; Manoharan,Muthiah; Capaldi,Daniel C.; Krotz,Achim; Cole,Douglas L.; Guzaev,Andrei, Process for the synthesis of oligomeric compounds.
  213. Ravikumar,Vasulinga T.; Manoharan,Muthiah; Capaldi,Daniel C.; Krotz,Achim; Cole,Douglas L.; Guzaev,Andrei, Process for the synthesis of oligomeric compounds.
  214. Ravikumar,Vasulinga; Manoharan,Muthiah; Capaldi,Daniel C.; Krotz,Achim; Cole,Douglas L.; Guzaev,Andrei P., Process for the synthesis of oligomeric compounds.
  215. Vasulinga T. Ravikumar ; Muthiah Manoharan ; Daniel C. Capaldi ; Achim Krotz ; Douglas L. Cole ; Andrei Guzaev, Process for the synthesis of oligomeric compounds.
  216. Zacharia S. Cheruvallath ; Vasulinga T. Ravikumar ; Douglas L. Cole, Process for the synthesis of oligomeric compounds.
  217. Ravikumar Vasulinga T., Process for the synthesis of oligomeric phosphite, phosphodiester, phosphorothioate and phosphorodithioate compounds.
  218. Leuck, Michael; Wolter, Andreas; Stumpe, Alfred, Process for the synthesis of oligonucleotides.
  219. Klem Robert E. ; Marvin William B. ; Riley Timothy A., Process for the synthesis of oligonucleotides and analogs with low water oxidation step.
  220. Ross,Bruce; Song,Quanlai, Process of purifying phosphoramidites.
  221. Manoharan Muthiah, Processes for the synthesis of oligomeric compounds.
  222. Ravikumar, Vasulinga T.; Capaldi, Daniel C.; Cole, Douglas L., Processes for the synthesis of oligomers using phosphoramidite compositions.
  223. Manoharan, Muthiah; Guzaev, Andrei, Processes for the synthesis of oligonucleotide compounds.
  224. Portereiko, Michael F.; Alexandrov, Nickolai, Promoter, promoter control elements, and combinations, and uses thereof.
  225. Portereiko, Michael F.; Alexandrov, Nickolai, Promoter, promoter control elements, and combinations, and uses thereof.
  226. Cheruvallath Zacharia S. ; Capaldi Daniel C. ; Ravikumar Vasulinga T. ; Cole Douglas L., Protecting group for synthesizing oligonucleotide analogs.
  227. Cheruvallath Zacharia S. ; Capaldi Daniel C. ; Ravikumar Vasulinga T. ; Cole Douglas L., Protecting group for synthesizing oligonucleotide analogs.
  228. Cheruvallath Zacharia S. ; Capaldi Daniel C. ; Ravikumar Vasulinga T. ; Cole Douglas L., Protecting group for synthesizing oligonucleotide analogs.
  229. Song,Quanlai; Ross,Bruce S., Protection of nucleosides.
  230. Cheruvallath Zacharia S. ; Ravikumar Vasulinga T. ; Cole Douglas L. ; Capaldi Daniel C., Reagent useful for synthesizing sulfurized oligonucleotide analogs.
  231. Cheruvallath Zacharia S. ; Ravikumar Vasulinga T. ; Cole Douglas L. ; Capaldi Daniel C., Reagent useful for synthesizing sulfurized oligonucleotide analogs.
  232. Zacharia S. Cheruvallath ; Vasulinga T. Ravikumar ; Douglas L. Cole ; Daniel C. Capaldi, Reagent useful for synthesizing sulfurized oligonucleotide analogs.
  233. Nelson, Paul S.; Mackie, Hugh; Murphy, Andrew, Reagents utilizing a serinol scaffold for labeling synthetic oligonucleotides.
  234. Sanghvi Yogesh S. ; Guo Zhiqiang, Recovery of triarylmethyl halide protecting groups cleaved during oligonucleotide synthesis.
  235. Chiarello, Ronald H.; Liu, Wing; Yokobata, Kathy E., Rhodamine-based fluorophores useful as labeling reagents.
  236. Myers,Andrew G.; Plowright,Alleyn T., Saframycins, analogues and uses thereof.
  237. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Short antisense compounds with gapmer configuration.
  238. Hatala, Paul J.; Kurz, Markus, Solid support reagents for synthesis.
  239. de Fougerolles, Antonin; Elbashir, Sayda M., Split dose administration.
  240. Seth, Punit P.; Prakash, Thazha P.; Swayze, Eric E., Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom.
  241. Prakash, Thazha P.; Swayze, Eric E., Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom.
  242. Seth, Punit P.; Swayze, Eric E., Substituted alpha-L-bicyclic nucleosides.
  243. Moore, Max; Krotz, Achim H.; Andrade, Mark; Scozzari, Anthony N., Synthesis of oligonucleotides on solid support.
  244. Dellinger,Douglas J.; Perbost,Michael G. M.; Caruthers,Marvin H.; Betley,Jason R., Synthesis of polynucleotides using combined oxidation/deprotection chemistry.
  245. Chu, Chi-Yuan; Lee, Wei-Der; Li, Wensen; Hwang, Chan Kou, Synthesis of β-nucleosides.
  246. Manoharan, Muthiah; Guzaev, Andrei, Synthetic methods and intermediates for triester oligonucleotides.
  247. Smith Lloyd M. ; Hood Leroy E. ; Hunkapiller Michael W. ; Hunkapiller Tim J. ; Connell Charles R., Tagged extendable primers and extension products.
  248. Smith, Lloyd M.; Hood, Leroy E.; Hunkapiller, Michael W.; Hunkapiller, Timothy; Connell, Charles R., Tagged extendable primers and extension products.
  249. Chakraborty, Tirtha; Bancel, Stephane; Hoge, Stephen G.; Roy, Atanu; de Fougerolles, Antonin; Afeyan, Noubar B., Terminally modified RNA.
  250. Prakash, Thazha P.; Swayze, Eric E., Tetrahydropyran nucleic acid analogs.
  251. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  252. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  253. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  254. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  255. Beaucage, Serge L; Chmielewski, Marcin K, Thermolabile hydroxyl protecting groups and methods of use.
  256. Beaucage,Serge L.; Grajkowski,Andrzej; Wilk,Andrzej, Thermolabile hydroxyl protecting groups and methods of use.
  257. Beaucage, Serge L.; Wilk, Andrzej; Grajkowski, Andrzej, Thermolabile phosphorus protecting groups, associated intermediates and methods of use.
  258. Bolchakova, Elena; Rozzelle, James, Thermus brockianus nucleic acid polymerases.
  259. Bolchakova, Elena; Rozzelle, James, Thermus scotoductus nucleic acid polymerases.
  260. Dellinger, Douglas J.; Sierzchala, Agnieszka B.; Turner, John; Myerson, Joel; Kupihar, Zoltan; Ferreira, Fernando; Caruthers, Marvin H.; Dellinger, Geraldine F., Thiocarbon-protecting groups for RNA synthesis.
  261. Dellinger, Douglas J.; Sierzchala, Agnieszka; Turner, John; Myerson, Joel; Kupihar, Zoltan; Ferreira, Fernando; Caruthers, Marvin H.; Dellinger, Geraldine F., Thiocarbon-protecting groups for RNA synthesis.
  262. Seth, Punit P.; Swayze, Eric E.; Hanessian, Stephen; Schroeder, Benjamin R.; Giacometti, Robert D.; Merner, Bradley L., Tricyclic nucleic acid analogs.

문의처: helpdesk@kisti.re.kr전화: 080-969-4114

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로